Skip to content

Jinghua Zhao

3 papers in the library · publishing 2019-2026

Papers

Sort Most recent Most cited

(2R,6R)-HNK improved LPS-induced depression-like behavior by inhibiting Vcam1/Caspase-1/IL-1β pathway.

International Immunopharmacology August 1, 2026 Jinghua Zhao, Ruxin Zhang, Jiarui Pan et al.

Depression-like behavior is closely associated with neuroinflammation. Lipopolysaccharide (LPS) can activate N-methyl-d-aspartate receptors and induce cellular pyroptosis and neuroinflammation, thereby triggering depression-like behavior in animals. The ketamine metabolite (2R,6R)-hydroxynorketamine (HNK) exerts significant antidepressant-like effects without the adverse effects associated with...

Low-dose ketamine improves LPS-induced depression-like behavior in rats by activating cholinergic anti-inflammatory pathways.

ACS Chemical Neuroscience February 3, 2020 Jinghua Zhao, XueJie Liu, Daiyue Chang et al.

About 16% of the world's population has major depressive disorder. Traditional antidepressants have slow effect rates and low response rates. Many studies have shown that low doses of ketamine can produce rapid and effective antidepressant effects. However, its mechanism of action needs further exploration. Lipopolysaccharide (LPS) was used to establish a depression model in rats and PC12 nerve...

Effect of ketamine combined with DHA on lipopolysaccharide-induced depression-like behavior in rats.

International Immunopharmacology August 1, 2019 Daiyue Chang, Jinghua Zhao, Xintong Zhang et al.

Depression has become a common mental illness, and studies have shown that neuroinflammation is associated with depression. Ketamine is a rapid antidepressant. In order to obtain better antidepressant effects, it is necessary to explore the efficacy of combination therapy with ketamine and other antidepressants. DHA is an unsaturated fatty acid with excellent application prospects due to its...